Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 7 Issue 12, December 2022

Tecovirimat blocks monkeypox replication

Shown is a coloured transmission electron microscope image of newly formed human monkeypox virus particles in an infected cell. In this issue, phylogenetic analysis of a monkeypox virus that was isolated from the first clinical case in France during the 2022 international outbreak is presented, together with an analysis of its in vitro sensitivity to the FDA-approved drug tecovirimat.

See Frenois-Veyrat et al.

Image: Ms Cécile Enfroy (IRBA, France) and Ms Myriam Oger (IRBA, France). Cover Design: Valentina Monaco.

Editorial

  • Reports of diphtheria cases in asylum seekers in the UK remind us that understanding and mitigating the risks posed by infectious diseases to disadvantaged peoples remain important.

    Editorial

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Prochlorococcus is the most abundant photosynthetic organism in the ocean, but single-cell measurements and model simulations reveal that this organism might obtain only 20% of the carbon required for growth from photosynthesis in the deep water column.

    • María del Carmen Muñoz-Marín
    News & Views
Top of page ⤴

Research

Top of page ⤴

Search

Quick links